Effect of lansoprazole on intragastric pH - Comparison between morning and evening dosing

Digestive Diseases and Sciences

Volumn 37, Issue 6, 1992, Pages 882-890

  Hongo, Michio ^a   Ohara, Shuichi ^a   Hirasawa, Yorihisa ^a   Abe, Shinichiro ^a   Asaki, Shigeru ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antisecretory effect; intragastric pH; lansoprazole; pH monitoring; proton pump inhibitor

Indexed keywords

LANSOPRAZOLE; PROTON PUMP;

ACID SECRETION; ADULT; ARTICLE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH PH;

ADENOSINETRIPHOSPHATASE; ADULT; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; GASTRIC ACIDITY DETERMINATION; HUMAN; HYDROGEN-ION CONCENTRATION; MALE; MONITORING, PHYSIOLOGIC; OMEPRAZOLE;

EID: 0026631707     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF01300386     Document Type: Article

References (28)

1. Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles
2. Effect of a substituted benzimidazole (H149/94) on gastric acid secretion in man
3. Substituted benzimidazoles inhibit gastric acid secretion by blocking the (H++K+) ATPase
4. Randomized, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer
5. Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcers
6. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial
7. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine and ranitidine resistance duodenal ulcers
8. Effect of omeprazole—a gastric proton pump inhibitor—on pentagastrin stimulated acid secretion in man
9. The effects of famotidine and omeprazole on 24-hour intragastric pH of normal subjects
10. Effect of daily oral omeprazole on 24 hour intragastric acidity
11. Technical aspects of intraluminal pH-metry in man: Current status and recommendations
12. Twenty four hour intragastric acidity analysis for the future
13. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and in rats
14. Phase I study of lansoprazole (AG-1749) antiulcer agent-Capsule form
15. Analysis of ambulatory 24-hour intragastric pH monitoring-comparison of the effects of cimetidine 200 mg QID and 800 mg UID
16. pH stability and activity curve of pepsin with special reference to their clinical importance
17. Reduction of twenty-four hour gastric acidity with combination drug therapy in patients with duodenal ulcer
18. Long-term ambulatory gastric pH monitoring: Validation of a new method and effect of H2-antagonists
19. Effects of AG-1749 (lansoprazole) and its metabolites on acid secretion and experimental ulcers
20. Low dose omeprazole: Lack of consistent effect on intragastric acidity and nocturnal and stimulated acid out-put
21. Effect of repeated once-daily, oral omeprazole on gastric secretion
22. Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity
23. Inhibition of acid secretion in isolated glands by substituted benzimidazoles
24. Doseresponse study of omeprazole on meal stimulated gastric acid secretion and gastrin release
25. Inhibition of pentagastrin-stimulated and nocturnal secretion by ranitidine, a new H2 receptor antagonist
26. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man
27. Intragastric acidity under 28-day omeprazole treatment
28. Effect of omeprazole, a substituted benzimidazole, on 24-hour intragastric acidity in patients with peptic ulcer disease